Interventions in Clinical Care

As evidenced in the references below, DPRG has several decades of experience in the conduct of experimental and quasi-experimental studies of interventions to improve clinical care among physicians and large delivery systems in numerous states. Below we highlight a recent example related to the goals of the Affordable Care Act.

 

Patient Navigator intervention to reduce hospital readmissions among high-risk safety-net patients

Affordability and Burden of Medical and Pharmaceutical Costs

The burden of medical and drug expenditures, especially for the elderly and disabled, is a major theme in DPRG’s policy research.  An example is our unique collaboration with the Center for Medicaid and Medicare Services to create and implement routine measures of cost-related medication nonadherence (CRN) among Medicare beneficiaries.  With NIA funding, DPRG investigators developed and validated measures of CRN and integrated the measures into the annual Medicare Current Beneficiary Survey starting in 2004.  Other investigators have since used similar or identical measures of CRN in numero

Effects of Pharmacy Benefit Limits and Expansions

DPRG faculty have placed major emphasis on investigating the impacts of changes in drug coverage on use of medicines, affordability, and clinical outcomes.  For example, we conducted the first well-controlled studies of the effect of state Medicaid caps on the number of monthly prescriptions, which demonstrated reductions in use of both nonessential and essential medications, as well as increased need for institutional and acute services to treat exacerbations of somatic and mental illnesses.  In addition, DPRG investigators recently showed that a Medicaid policy of requiring drug prior aut

Domestic Health Insurance and Pharmaceutical Policy

New legislative and regulatory initiatives continually shape the US health policy environment.  Policy changes, such as, new health insurance benefit limits or expansions, are intended to guard against overuse of health services control costs, or improve access and quality of healthcare. However, many new policies are not based on convincing evidence of their efficacy in achieving these objectives.

Toni Peters

Corresponding Member of the Faculty

Until her retirement (December 31, 2013), Dr. Peters was an Associate Professor in the Department of Population Medicine (DPM), and the Associate Director of the Academy Center for Teaching and Learning at Harvard Medical School (HMS).  Presently, she is a Lecturer in DPM and a consultant to the HMS Center for Primary Care. She received a BA in Psychology from Pennsylvania State University and a PhD in Educational Psychology from SUNY at Buffalo. From 1986-1991, she was the Associate Director for Educational Research and Evaluation at SUNY/Buffalo. She joined DPM in 1992.

Jeanne Madden

Lecturer

Dr. Madden is a Lecturer in the Department of Population Medicine, working primarily with the Division of Health Policy and Insurance Research. At present, she is leading a qualitative study on the experiences of individuals with bipolar disorder as they navigate complex insurance benefits, within a larger PCORI investigation of the impact of high deductible health plans on individuals with bipolar disorder.  Dr.

Katherine Levandoski

Research Fellow

Katherine Levandoski is a research assistant in the Patient Oriented Research on the Epidemiology of Skin Diseases (PORES) Unit in the Department of Population Medicine, Harvard Pilgrim Health Care Institute and the Department of Dermatology, Massachusetts General Hospital. She received her bachelor's degree in Molecular, Cellular, and Developmental Biology from Yale University. She is a medical student at the Johns Hopkins School of Medicine. She is pursuing a year of research with the PORES Unit prior to completing her final year of medical school.

Anjali Kaimal

Faculty

Anjali Kaimal, MD is an Assistant Professor in the Department of Obstetrics, Gynecology, and Reproductive Biology at Harvard Medical School and a Maternal-Fetal Medicine Specialist at Massachusetts General Hospital.  Her research program is focused on the definition, design, execution, and dissemination of evidence-based, patient-centered interventions to improve the quality and effectiveness of obstetric care, particularly regarding mode of delivery and interventions during pregnancy including induction of labor, prenatal testing, and medications for management of medical complications.  S